Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 5:00 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 769–792 of 10,295 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: PAIN Clear all

Conditions: Pain, Burning, Pain, Crushing, Pain, Migratory, Pain, Radiating, Pain, Splitting
Interventions: JNJ-42160443, Placebo; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 17
States / cities: Birmingham, Alabama • Tucson, Arizona • Laguna Hills, California + 14 more

Conditions: Acute Pain, Arthropathy of Knee, Arthropathy of Hip, Pain, Postoperative, Kidney Transplant Donor, Bariatric Surgery Candidate
Interventions: NSS-2 Bridge; Device
Lead sponsor: Jacques E. Chelly; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 3
States / cities: Pittsburgh, Pennsylvania

Conditions: Patient Comfort
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Chronic Pain
Interventions: Dronabinol; Drug
Lead sponsor: Daisy Pharma Opioid Venture, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 280 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Interstitial Cystitis, Bladder Pain Syndrome, Microbial Colonization
Interventions: Heparin & Alkalinized Lidocaine Bladder Instillation; Drug
Lead sponsor: Walter Reed National Military Medical Center; Federal
Eligibility: 18 Years and older · Female only
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Chronic Pain
Interventions: Mindful Walking for Adults with Chronic Pain; Behavioral
Lead sponsor: Clemson University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Clemson, South Carolina

Conditions: Angina Pectoris
Interventions: T89; Drug
Lead sponsor: Tasly Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 15
States / cities: Tucson, Arizona • Beverly Hills, California • Corona, California + 11 more

Conditions: Unilateral Primary Osteoarthritis of Knee, Primary Osteoarthritis of Knee Nos
Interventions: Placebo TENS, Active TENS; Device
Lead sponsor: Barbara A Rakel; Other
Eligibility: 30 Years to 100 Years
Enrollment: 317 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Back Pain, Neck Pain
Interventions: THC/CBD, THC, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 21 Years to 84 Years
Enrollment: 157 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Bowel Dysfunction, Constipation
Interventions: Placebo, Alvimopan, Alviompan; Drug
Lead sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA); Industry
Eligibility: 18 Years and older
Enrollment: 485 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 119
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 104 more

Conditions: Pain, Bone Neoplasm, Neoplasm Metastasis
Interventions: ibandronate [Bondronat], zoledronic acid; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 163 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 26
States / cities: Birmingham, Alabama • Sedona, Arizona • Ocoee, Florida + 22 more

Conditions: Cataract
Interventions: Nepafenac 0.3% Oph Susp, Placebos, Nepafenac 0.3% Oph Susp (reference); Drug
Lead sponsor: Actavis Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 448 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Pain
Interventions: Lidocaine, Calming Music, No Music; Other
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older · Female only
Enrollment: 251 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: LC Pelvic Fracture
Interventions: LC fracture surgical fixation, LC fracture non-operative management; Procedure
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 80 Years
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 2
States / cities: Indianapolis, Indiana • Baltimore, Maryland

Conditions: Chest Pain, Coronary Artery Disease, Cardiovascular Diseases, Coronary Heart Disease, Angina Pectoris, CAD, CVD, CHD
Interventions: CORUS CAD (ASGES); Diagnostic Test
Lead sponsor: CardioDx; Industry
Eligibility: 18 Years and older
Enrollment: 713 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 13
States / cities: Chandler, Arizona • Hiawassee, Georgia • Suwanee, Georgia + 10 more

Conditions: Pain
Interventions: Transcutaneous Electrical Nerve Stimulation (TENS); Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: New Haven, Connecticut

Conditions: Cyclic Vomiting Syndrome
Interventions: 3mg AZ-010, 1mg AZ010, Staccato Placebo; Combination Product
Lead sponsor: Alexza Pharmaceuticals, Inc.; Other
Eligibility: 18 Years to 60 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 18
States / cities: Lancaster, California • Los Angeles, California • San Diego, California + 14 more

Conditions: Acute Pain, Surgery, Regional Anesthesia
Interventions: Epidural, TAP Block; Drug
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Menorrhagia, Dysfunctional Uterine Bleeding, Leiomyoma, Pelvic Pain, Endometriosis
Interventions: Conventional Laparoscopic Hysterectomy (LH), Robot Assisted Hysterectomy; Procedure
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Chronic Back Pain, Depression, Aging, Musculoskeletal Pain
Interventions: Behavioral Intervention Group (MOTIVATE); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 60 Years to 99 Years
Enrollment: 214 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Dallas, Texas • Houston, Texas

Conditions: Postoperative Pain
Interventions: Bupivacaine, Saline (NaCl 0,9 %) (placebo); Drug
Lead sponsor: United States Naval Medical Center, Portsmouth; Federal
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Portsmouth, Virginia

Conditions: Esophageal Spasm
Interventions: Magnesium sulfate, Normal Saline; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pain, Post Operative Analgesia, Opioid Consumption, Postoperative
Interventions: Lidocaine HCl 0.8% in D5W, Dextrose 5% in water; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 2,290 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Colorectal Cancer, Depression, Fatigue, Liver Cancer, Pain, Pancreatic Cancer
Interventions: medical chart review, questionnaire administration, study of socioeconomic and demographic variables, quality-of-life assessment; Other · Procedure
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Duarte, California

Search by objective public record fields.

A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain

NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries

Evaluation of Pain and Discomfort in the Cardiac Catheterization Lab

Dronabinol Opioid Sparing Evaluation (DOSE) Trial

The Female Microbiome in Patients Undergoing Bladder Instillation Therapy

Mindful Walking for Adults With Chronic Pain

Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina

Effect of TENS for Pain and Function After Total Knee Replacement

Safety and Efficacy of Oral Cannabis in Chronic Spine Pain

Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain

A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease

Clinical Endpoint Study of Nepafenac 0.3% Opthalmic Suspension

Women's Mammography Study to Improve Comfort During Mammography

Pelvis RCT: Impact of Surgery on Pain in Lateral Compression Type Pelvic Fractures

A Registry to Evaluate Patterns of Care Associated With the Use of Corus CAD (or ASGES) in Primary Care Settings

Transcutaneous Electrical Nerve Stimulation (TENS) for Intrauterine Device (IUD) Insertion Pain

Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome

Comparison of Epidural and TAP Block in Abdominal Surgery

Study of Conventional Laparoscopic Hysterectomy Versus Robot-Assisted Laparoscopic Hysterectomy at a Teaching Institution

MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression

RCT to Test Regional Anesthesia Effect on Decreased Opiate Use

Magnesium for Peroral Endoscopic Myotomy

The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery

Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer